Table 2.

Residual symptoms of ISI_extended (by descending prevalence) among individuals with full remission (N = 434)

Residual symptoms at remission	Percentage
Quality of sleep (≥2)	39.2%
Difficulty maintaining sleep (≥2)	27%
Fatigue (≥2)	24.7%
General daytime impairments (≥2)	23.5%
Mood (≥2)	23%
Cognition impairments (≥2)	22.6%
Early morning awakening (≥2)	22.1%
Difficulty initialing sleep (≥2)	21.9%
Daily activities (≥2)	16.4%
Quality of life (≥2)	15.7%
Interpersonal relationship (≥2)	13.4%
Noticeability (≥2)	13.1%
Morning refreshment (≤1)	11.8%
Worry (≥2)	9.9%